Trillium Therapeutics Inc (TRIL)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | |
| CEO: | Niclas Stiernholm |
| Employees: | 2,000 |
| Web site: | www.trilliumtherapeutics.com |
|
2488 DUNWIN DRIVE, MISSISSAUGA, A6, L5L 1J9
(416) 595-0627
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
-
Formally known as:
- STEM CELL THERAPEUTICS CORP
- STEM CELL THERAPEUTICS CORP
- STEM CELL THERAPEUTICS CP
- TRILLIUM THERAPEUTICS INC (CANADA)
| Date | Ratio |
|---|---|
| 2014-11-20 | 1:30 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the development of innovative therapies for the treatment of cancer. Its lead program, SIRPaFc, is an antibody-like fusion protein that blocks the activity of CD47, a molecule that allows tumor cells to escape destruction by the immune system. The company was founded on March 31, 2004 and is headquartered in Toronto, Canada.
Please log in first to see chart